AzTrials
AzTrials

Perioperative AnalgesiaNCT06210503

PENG Block in Comparison With FICB for Hip Reconstruction in Children

A study testing Pericapcelar group nerve block and Fascia iliaca compartment block in people with Perioperative Analgesia and Hip Dislocation, Developmental, run by Saint Petersburg State University, Russia at 1 site in Russia.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to test the hypothesis that performing a Pericapsular nerve group (PENG) block allows for more effective analgesia in the perioperative period during reconstructive surgery on the hip in children with cerebral palsy and spina bifida compared with Fascia illiaca compartment block… Read more about this study

Who is it for?
Ages 3 to 17 years
What is being tested?
Pericapcelar group nerve block and Fascia iliaca compartment block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
86 participants
Where
1 siteRussia
Study dates
4 Dec 2023to 1 Nov 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • reconstructive surgery on the hip joint
  • children with cerebral palsy/ spina bifida/organic brain injury
  • age 3 - 18 years.

Who cannot join

  • contraindications to the use of local anesthetics
  • contraindications to performing an invasive procedure
  • ASA > 3

Trial locations and contacts

1 site in 1 country.

Russia1 site
  • Saint-Petersburg State University

    Saint Petersburg

Other trials in Russia

About this study

Official title: The Comparison of Pericapsular Nerve Block and Fascia Iliaca Compartment Block in Children With Cerebral Palsy or Spina Bifida for Pain Management in Hip Surgery.

The goal of this clinical trial is to test the hypothesis that performing a Pericapsular nerve group (PENG) block allows for more effective analgesia in the perioperative period during reconstructive surgery on the hip in children with cerebral palsy and spina bifida compared with Fascia illiaca compartment block (FICB).

Read the detailed description

The main question it aims to answer is: Is the PENG block an effective and safe method of pain relief for hip surgery in children? Participants will be randomized into two equal groups. The group who underwent US - guided PENG block, and the group who underwent US - guided FICB . In both groups we used 0.5% ropivacaine. The same postoperative analgesia regimen was applied by intravenous acetaminophen , oral ibuprofen . In case of ineffectiveness of the prescribed drugs, promedol was used intramuscularly. The postoperative consumption of promedol, time to first rescue analgesia, numerical pain score (NRS) (for children from 7 years old), FLACC score, measurements of A.N.I. monitor MDMS and the side effects will be recorded

Being tested
Pericapcelar group nerve block, Fascia iliaca compartment block
Keywords
Anesthesia local, nerve block, postoperative pain, hip dislocation, children
Medical subject headings
Developmental Dysplasia of the Hip, Pain, Postoperative, Hip Dislocation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pericapcelar group nerve blockProcedure or surgery

    In the supine position, a high-frequency linear sensor is placed in the anterior superior iliac spine and then aligned with the ramus of the pubis by rotating the probe counterclockwise approximately 45 degrees. The iliopsoas muscle and tendon, femoral artery, and pectineus muscle were observed in this view.The iliopsoas muscle and its tendon are visualized, as well as the vascular and nerve bundle: femoral artery, vein, and nerve. The needle is inserted laterally to medially in a planar approach to place the tip in the musculofascial plane between the psoas tendon anteriorly and the ramus pubis posteriorly. After negative aspiration, local anesthetic will be gradually injected aspirating every 3 mL.

  • Fascia iliaca compartment blockProcedure or surgery

    In the supine position, a high-frequency linear sensor is placed in the inguinal fold. Scan starting lateral to the femoral artery and the nerve in the inguinal crease to identify the sartorius muscle, tracing the muscle to its origin to the anterior superior iliac spine. A shadow of the iliac crest bone and iliacus muscle will be visible, with the end point of injection being deep in the fascia iliaca and above the iliacus muscle at the lateral aspect of the iliacus muscle. After negative aspiration, local anesthetic will be gradually injected under the fascial plane, aspirating every 3 mL.

Study groups in NCT06210503
Study groupRoleWhat they receive
PENG groupActive comparatorThe patient will undergo pericapsular nerve blockade with 0.5% ropivacaine based on 3 mg/kg ropivacaine using ultrasound scanning.
Receives: Procedure: Pericapcelar group nerve block
FICB groupActive comparatorThe patient will undergo FICB with 0.5% ropivacaine based on 3 mg/kg ropivacaine using ultrasound scanning.
Receives: Procedure: Fascia iliaca compartment block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Opioids consumption

    Total dosage of opioids in postoperative period

    Measured: 24 hours

Secondary outcomes (3)
  1. Time to rescue analgesia

    Time to first accepted of opioid analgesia

    Measured: 24 hours

  2. Pain level

    Assessing level of pain. Using pain scales. Face, Legs, Activity, Cry, Consolability (FLACC) scale for children from 3 to 7 years old. The scale is scored in a range of 0-10 with 0 representing no pain, and 10 representing maximal pain. The numeric rating scale (NRS) is a verbal or written determination of a pain level on a scale from 0 to 10, in which 0 represents no pain and 10 represents excruciating pain.

    Analgesia-nociception index (ANI). Using "ANI Monitor".

    Measured: 2, 6, 12, 24 hours after completing the block

  3. Intraoperative level of analgesia

    Analgesia-nociception index (ANI). Using "ANI Monitor".

    Measured: Intraoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2024
  2. Study start4 Dec 2023
  3. Primary completion1 Nov 2025 (estimated)
  4. Study completion1 Nov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
86 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06210503
Sponsor's protocol ID
PENG vs FICB
Status last verified
Jul 2025
First submitted
21 Dec 2023
Last updated
8 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Pericapcelar group nerve block and Fascia iliaca compartment block in people with Perioperative Analgesia and Hip Dislocation, Developmental, run by Saint Petersburg State University, Russia at 1 site in Russia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 8 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Opioids consumption (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in